Back to top

Image: Bigstock

Canadian Natural (CNQ) Lags Q1 Earnings Estimates, Sales Top

Read MoreHide Full Article

An Earnings Miss: Exploration and production company, Canadian Natural Resources Limited (CNQ - Free Report) announced first-quarter 2018 operating earnings per share of 55 cents, nominally missing the Zacks Consensus Estimate of earnings of 57 cents.

Revenue Surpassed Estimates: Total revenues came in at $5,258 million, comfortably outperforming the Zacks Consensus Estimate of $4,162 million.

Key Stats:

Canadian Natural reported quarterly production of 1,123,546 barrels of oil equivalent per day (BOE/d), up from 876,907 BOE/d in the prior year quarter.

Oil and natural gas liquids (NGLs) output (accounting for more than 76% of total volumes) increased 42.9% to 854,558 barrels per day (Bbl/d). The production gains primarily reflect strong production and high reliability from the Horizon Phase 3 expansions and robust contribution from certain strategic acquisitions closed in 2017.Meanwhile, natural gas volumes declined 3.5% year over year to stand at 1,614 million cubic feet per day (MMcf/d).

Canadian Natural’s realized natural gas price were $2.74 per thousand cubic feet, compared with the year-ago quarter level of $3.25. Further, realized oil price declined to $43.06 per barrel from $47.05 in the first quarter of 2017.

Costs: The total expenses incurred in the quarter totaled C$4,600, reflecting an increase of 33.8% from the year ago level. Increased expenses are primarily attributed to higher production and transportation costs along with foreign exchange loss.

Estimate Revision Trend: Investors should note that the earnings estimate for Encana was revised downward by a penny in the last 30 days. The Zacks Consensus Estimate remained the same over the last 7 days.

Zacks Rank & Surprise History: Currently, Canadian Natural carries a Zacks Rank #1 (Strong Buy) which is subject to change following the earnings announcement. (You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.)

Coming to earnings surprise history, the company delivered an average positive earnings surprise of 0.78% in the trailing four quarters.

5 Medical Stocks to Buy Now

Zacks names 5 companies poised to ride a medical breakthrough that is targeting cures for leukemia, AIDS, muscular dystrophy, hemophilia, and other conditions.

New products in this field are already generating substantial revenue and even more wondrous treatments are in the pipeline. Early investors could realize exceptional profits.

Click here to see the 5 stocks >>


See More Zacks Research for These Tickers


Normally $25 each - click below to receive one report FREE:


Canadian Natural Resources Limited (CNQ) - free report >>